DITTA Statement on World Cancer Day

02.04.17

World Cancer Day 2017: Medical Technologies are helping

prevent premature deaths

Washington, USA, 4 February 2017—Today is World Cancer Day 2017, and DITTA is honoured to support its ambition of significantly reducing the illnesses and premature deaths caused by cancer by 2020[1]. DITTA is also proud to highlight the increasingly important role that medical technologies play in achieving these goals, by improving prevention, screening, early diagnosis, treatment, care and palliation of cancers.

DITTA member companies develop and manufacture medical imaging, Digital Health and radiotherapy technologies and solutions that are constantly improving the entire cancer care pathway. They are continuously investing in research to make screening and treatment more effective, affordable and accessible to the widest possible population.

DITTA Chair Patrick Hope says: “Our organization fully supports the aims of World Cancer Day. We believe that it is vital to maintain the widest public focus on this disease and to raise awareness of the continuing advances in treatment. It will help ensure policymakers and payers make full use of all available innovative technologies and treatments.” He continued: “Realising the full potential of modern medical technologies will contribute in maximising the benefits from earlier, accessing to more accurate diagnoses and to the improved outcomes this will bring. It is vital that as many patients as possible have access to modern diagnostic tests, early screening, and treatment.”

Medical imaging is increasingly important in advancing and improving cancer treatments. Powerful and effective non-invasive technologies make screening increasingly effective. This is driving earlier detection and intervention, improving outcomes and survival rates. Medical imaging also helps validate whether highly-targeted precision therapies are proving effective, allowing patients to have their treatments adjusted for the best available outcomes. Meanwhile, advances in radiotherapy are allowing care teams to treat and manage disease with increasing accuracy while reducing radiation doses at the same time. Combinations of modern imaging techniques and radiotherapy allow tumors to be targeted with previously unimagined levels of accuracy.

 

Meanwhile, the increasing power of Digitalisation in health is improving the care flow and the patient journey. Ability to share data quickly, in a safe way and accurately between all stakeholders in the patients’ care – including the patients themselves – is making true multidisciplinary care a reality. The efficiencies that Digital solutions bring to healthcare, particularly in the management of complex conditions such as cancer, will increasingly free up limited resources and allow more patients to benefit.

###

For more information, contact:

Patrick Hope

MITA

phope@medicalimaging.org

 

*DITTA is the united global industry voice for diagnostic imaging, radiation therapy, healthcare IT, electromedical and radiopharmaceuticals, representing more than 600 medical technology manufacturers, committed to improving health care and patient outcomes. DITTA was created in 2001 by four organisations: COCIR (Europe), JIRA (Japan), MEDEC (Canada) and MITA (United States). In 2012, DITTA was incorporated as a non-profit trade association in order to allow growth and enable partnership in global regulatory fora.  Since its inception, membership has grown significantly, and today counts ten associations amongst its members. In 2015, DITTA was granted the NGO status in official relationship with World Health Organization. Visit DITTA website at www.globalditta.org

###

About DITTA: DITTA is the global voice for diagnostic imaging, radiation therapy, healthcare IT, electromedical and radiopharmaceutical manufacturers to better communicate, coordinate and collaborate on matters of common interest between participating associations and member companies. DITTA includes more than 600 companies worldwide. DITTA membership is currently comprised of COCIR (Europe), JIRA (Japan), ITAC (Canada), MEDEC (Canada), MITA (United States), THAIMED (Thailand), IMEDA (Russia), CAMDI (China), ABIMED (Brazil) and KMDICA (Korea). DITTA enables participating associations and their member companies to work more effectively with international policymakers, organizations, professional associations and stakeholders. Since 2015, DITTA has the status of NGO in official relations with World Health Organisation.

More information on DITTA, visit the website www.globalditta.org

[1] https://en.wikipedia.org/wiki/World_Cancer_Day

  • PRESS CONTACT

    Tracy Cullen
    703-841-3282
    Tracy.Cullen@nema.org

  • MITA Smart Initiative

    Promoting patient safety and enhancing the quality of medical imaging technology with MITA Smart Standards. Learn More

  • Fluoro Pharma

    Why I Joined MITA – FluoroPharma Medical, Inc.

    Hear from Thomas Tulip, Ph.D, President, FluoroPharma Medical, Inc. on why his organization joined MITA.

    Learn More